Phluid Corporation Engages Syprosoft Engineering for the Development of an Ambulatory Diabetes Pump
IRVINE, Calif.--(BUSINESS WIRE)--Phluid Corporationannounced today that it has retained Syprosoft Engineering, a division of Syprosoft Inc., to assist in the development of an Ambulatory Diabetes Pump to be used for continuous subcutaneous insulin infusion.
“Our medical device and its software are critical to its operation, and as a startup we needed to get the right people on the task,” said Paul DiPerna, President of Phluid Corporation. “After talking with many folks in the industry we’ve chosen Syprosoft to design, develop and validate our software,” concluded DiPerna.
“We are delighted to have been chosen by Phluid Corporationto help with the development of the Ambulatory Diabetes Pump,” said Dipu Ghosh, President & Founder of Syprosoft Inc. “We look forward to augmenting their team and helping realize their product development goals.”
About Phluid Corporation
Phluid Corporation is a privately held start-up company based in Laguna Hills, California. It is developing an Ambulatory Diabetes Pump to be used for continuous subcutaneous insulin infusion. The pump uses a novel approach to provide patients with the insulin infusion therapy they need to keep their blood glucose levels within target ranges. There are an estimated 20 million Americans who have diabetes that could potentially benefit from this device. For more information please visit www.phluidcorp.com.
About Syprosoft Engineering
Founded in 2002, Syprosoft Inc. is a privately held company located in Irvine, California. Syprosoft Engineering, a division of Syprosoft Inc., provides a full range of R&D services, including software, electrical and mechanical engineering. As an extension of a client’s engineering department, Syprosoft Engineeringprovides the critical skills and expertise at the right time to help its clients meet their product development goals. For more information please visit www.syprosoft.com.
This press release contains forward-looking statements. These are based on current expectations and beliefs and are subject to numerous risks, uncertainties and change. The parties disclaim any obligation to update any forward-looking statement as a result of developments occurring after this press release.